Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice

Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phrase 3...